Skip to content
MarketScale
‹ Back to IndustriesHealthcare

5 Ways Healthcare Organizations are Using SDOH to Make a Difference

So much of our overall health is impacted by various socioeconomic factors, which don’t involve ever stepping foot into a doctor’s office, clinic or hospital. Social determinants of health—commonly referred to as SDOH—and healthcare utilization have an evidenced correlation. It’s estimated that as much as 80% of socioeconomic factors determine our health. That’s significant. As…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
5 Ways Healthcare Organizations are Using SDOH to Make a Difference

So much of our overall health is impacted by various socioeconomic factors, which don’t involve ever stepping foot into a doctor’s office, clinic or hospital. Social determinants of health—commonly referred to as SDOH—and healthcare utilization have an evidenced correlation. It’s estimated that as much as 80% of socioeconomic factors determine our health. That’s significant. As healthcare organizations—hospitals, health systems and payers—look to curb costs and operate more efficiently, there’s growing evidence pointing to the importance of understanding and addressing SDOH.

Healthcare organizations are using SDOH data in the following ways:

  1. Risk stratification
    Socioeconomic data can be used as one of a few sources to determine what level of risk a patient/member is for high utilization—low risk, moderate risk, rising risk, high risk, etc. In addition to using clinical and claims data, adding socioeconomic data provided by a third party can enhance risk scores built in-house. As a result, organizations can build comprehensive models to segment populations and better manage health outcomes.
  2. Predictive analytics
    By combining socioeconomic data with clinical and claims information, healthcare organizations have been able to identify potential high-risk groups/individuals and determine which socio-clinical interventions to deploy.
  3. Social needs referrals
    SDOH data has been a boon for social workers and care managers. Armed with the right information and tools, they’re able to make accurate referrals to community-based organizations like food banks, transportation services, temporary housing assistance, job training programs and financial aid services. SDOH data helps knock down barriers to care that often lead to bigger, more costly healthcare issues down the line. SDOH data helps solve that. For example, a produce-prescription program in Ward 8 of Washington, DC brought a diversified team together to improve health for pre-diabetic, diabetic and hypertensive individuals who faced food insecurity. The program provides a $20 per week prescription for fruits and vegetables, as well as a nutritional consult. Improvements, such as a decrease in ED visits and hospitalizations and an increase in primary care, have already been seen.
  4. Individual care interventions
    Individual-level datasets inform care managers of specific socioeconomic needs the organization can directly address. For example, without reliable public or personal transportation, patients may skip annual checkups, follow-up visits and recommended screenings. Free rides can be offered to and from the physician’s office to ensure they can make their appointment.

Aggregated data sets are being leveraged to identify which specific neighborhoods would benefit most from SDOH interventions. For example, hospitals in areas with high numbers of homelessness have provided patients facing housing instability with a safe and supportive place to heal after hospital discharge.

FinThrive Social Determinant Risk Attributes delivers individualized (evidence-based data from 90,000+ sources and matched at patient level) and aggregated (neighborhood data down to the ZIP + 4 level) socioeconomic datasets.

Learn more about how FinThrive is advancing health equity through data. See Our SDOH Story.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare digital transformation stalls when teams stay disconnected

Healthcare digital transformation stalls when teams stay disconnected

Despite over 70% of healthcare executives prioritizing digital transformation, fragmented communication and information silos are hindering progress. Effective teamwork and integration are critical for achieving these goals. Bridging these gaps could enhance results in the healthcare industry's digital initiatives.

  • 01Over 70% of healthcare executives prioritize digital transformation.
  • 02Fragmented communication and information silos limit progress.
  • 03Effective integration is crucial for successful digital initiatives.

Jul 15, 2026

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512